UAB First in U.S. to Offer Speedier Precise Cancer TherapyMay 08, 2008BIRMINGHAM, Ala. - The University of Alabama at Birmingham (UAB) this month became the first U.S. medical center to offer a speedier cancer radiation therapy. The new technique can turn a 20-minute radiotherapy session into a 90-second session for selected patients. Additionally, the new therapy saves healthy human tissue from unwanted radiation exposure at rates that are the same or better than other radiotherapy techniques, according to doctors at the UAB Comprehensive Cancer Center. The new therapy is called RapidArc, which is the next-generation of intensity-modulated radiation therapy (IMRT). Conventional IMRT was introduced in the 1990s as a way to deliver multiple beams of radiation to a tumor, and minimize damage to nearby healthy tissues. RapidArc is an advancement on the earlier technology with radiation delivery times up to eight times faster than conventional IMRT, said the system's manufacturer Varian Medical Systems, Inc.
"RapidArc is an important advance for us and our patients," said John Fiveash, M.D., an associate professor of radiation oncology at UAB and Cancer Center scientist. "Knowing that we can reduce delivery times to less than two minutes per day is important considering what cancer care involves emotionally and physically." ALABAMIAN FIRST IN NATION TO BENEFIT Varian technicians added the RapidArc capability to UAB's existing IMRT machine during the last week of April. The upgrades serve as a kind of guidance system, much like a jet's automatic pilot, so that IMRT delivery can happen during a single rotation of the machine's arm around the patient. The first U.S. patient to be given the new therapy is an Alabama man with early-stage prostate cancer whose treatment started May 6, Fiveash said. Faster radiation delivery times reduce the chances that a slight move will affect the accuracy of the radiotherapy targeting. Also, it means patients spend less time and feel less discomfort in the treatment room, he said. "We presently treat many patients with very complex treatment plans," said John Brinkerhoff, R.Ph., M.B.A., C.M.P.E., executive administrator of UAB's Department of Radiation Oncology. "We have a head and neck cancer plan that would normally require a patient to lie still for 20 minutes with their face in a cushioned stability mask. With RapidArc, they are required to remain still for only 90 seconds." The new system incorporates powerful computers to help doctors arrive at a radiotherapy treatment strategy after pouring over thousands of biological and mathematical variables, including medical scans of each patient's tumor. University of Alabama at Birmingham | |||||||||||||||||||||
|
Related Radiation Therapy News Articles New clinical trial for patients with asbestos-associated lung cancer The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos. Refusal of suicide order: Why tumor cells become resistant Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body. UT Southwestern urologists identify seven biomarkers that may help pinpoint prostate cancer recurrence A simple blood test may help doctors better predict whether prostate cancer will recur or spread in patients who have undergone surgery for the disease, UT Southwestern Medical Center researchers have found. Radiation therapy prolongs life in men with recurrent prostate cancer Men whose tumors recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence. Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems Adults who survived childhood Hodgkin's Lymphoma should be especially vigilant about cancer and cardiovascular screenings, according to researchers from Wake Forest University Baptist Medical Center and colleagues. OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer. Invasive methods unnecessary for prostate cancer radiation therapy treatment planning Modern 3-D computed tomography (CT) is an effective method for locating the prostatic apex for radiation therapy treatment planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related side effects. CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients New data show that CAPHOSOL® (www.caphosol.com), an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients undergoing chemotherapy and radiation therapy. Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers The number of women undergoing mastectomy (total breast removal) for early-stage breast cancer has increased in the last three years at Mayo Clinic in Rochester. The increase follows a steady decline during the prior seven years. Researchers find way to make tumor cells easier to destroy Tumors have a unique vulnerability that can be exploited to make them more sensitive to heat and radiation, researchers at Washington University School of Medicine in St. Louis report. More Radiation Therapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||